<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">35328506</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>13</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Neuroinflammation and COVID-19 Ischemic Stroke Recovery-Evolving Evidence for the Mediating Roles of the ACE2/Angiotensin-(1-7)/Mas Receptor Axis and NLRP3 Inflammasome.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3085</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms23063085</ELocationID><Abstract><AbstractText>Cerebrovascular events, notably acute ischemic strokes (AIS), have been reported in the setting of novel coronavirus disease (COVID-19) infection. Commonly regarded as cryptogenic, to date, the etiology is thought to be multifactorial and remains obscure; it is linked either to a direct viral invasion or to an indirect virus-induced prothrombotic state, with or without the presence of conventional cerebrovascular risk factors. In addition, patients are at a greater risk of developing long-term negative sequelae, i.e., long-COVID-related neurological problems, when compared to non-COVID-19 stroke patients. Central to the underlying neurobiology of stroke recovery in the context of COVID-19 infection is reduced angiotensin-converting enzyme 2 (ACE2) expression, which is known to lead to thrombo-inflammation and ACE2/angiotensin-(1-7)/mitochondrial assembly receptor (MasR) (ACE2/Ang-(1-7)/MasR) axis inhibition. Moreover, after AIS, the activated nucleotide-binding oligomerization domain (NOD)-like receptor (NLR) family pyrin domain-containing 3 (NLRP3) inflammasome may heighten the production of numerous proinflammatory cytokines, mediating neuro-glial cell dysfunction, ultimately leading to nerve-cell death. Therefore, potential neuroprotective therapies targeting the molecular mechanisms of the aforementioned mediators may help to inform rehabilitation strategies to improve brain reorganization (i.e., neuro-gliogenesis and synaptogenesis) and secondary prevention among AIS patients with or without COVID-19. Therefore, this narrative review aims to evaluate the mediating role of the ACE2/Ang- (1-7)/MasR axis and NLRP3 inflammasome in COVID-19-mediated AIS, as well as the prospects of these neuroinflammation mediators for brain repair and in secondary prevention strategies against AIS in stroke rehabilitation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Che Mohd Nassir</LastName><ForeName>Che Mohd Nasril</ForeName><Initials>CMN</Initials><Identifier Source="ORCID">0000-0002-2019-4565</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian 16150, Kelantan, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zolkefley</LastName><ForeName>Mohd K I</ForeName><Initials>MKI</Initials><Identifier Source="ORCID">0000-0002-7824-0093</Identifier><AffiliationInfo><Affiliation>Faculty of Industrial Sciences and Technology, Universiti Malaysia Pahang, Lebuhraya Tun Razak, Gambang Kuantan 26300, Pahang, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramli</LastName><ForeName>Muhammad Danial</ForeName><Initials>MD</Initials><Identifier Source="ORCID">0000-0002-5261-0391</Identifier><AffiliationInfo><Affiliation>Department of Diagnostic and Allied Health Science, Management and Science University (MSU), Shah Alam 40100, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norman</LastName><ForeName>Haziq Hazman</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>Anatomy Unit, International Medical School (IMS), Management and Science University (MSU), Shah Alam 40100, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdul Hamid</LastName><ForeName>Hafizah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mustapha</LastName><ForeName>Muzaimi</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8404-0506</Identifier><AffiliationInfo><Affiliation>Faculty of Industrial Sciences and Technology, Universiti Malaysia Pahang, Lebuhraya Tun Razak, Gambang Kuantan 26300, Pahang, Malaysia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Universiti Sains Malaysia, Jalan Raja Perempuan Zainab II, Kubang Kerian 16150, Kelantan, Malaysia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058847">Inflammasomes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071199">NLR Family, Pyrin Domain-Containing 3 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011506">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000090063">Proto-Oncogene Mas</NameOfSubstance></Chemical><Chemical><RegistryNumber>9041-90-1</RegistryNumber><NameOfSubstance UI="D000803">Angiotensin I</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="C000705307">ACE2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>IJ3FUK8MOF</RegistryNumber><NameOfSubstance UI="C118790">angiotensin I (1-7)</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000803" MajorTopicYN="N">Angiotensin I</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="N">Angiotensin-Converting Enzyme 2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058847" MajorTopicYN="N">Inflammasomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000083242" MajorTopicYN="N">Ischemic Stroke</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071199" MajorTopicYN="N">NLR Family, Pyrin Domain-Containing 3 Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000090862" MajorTopicYN="N">Neuroinflammatory Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000090063" MajorTopicYN="N">Proto-Oncogene Mas</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE2</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">NLRP3 inflammasome</Keyword><Keyword MajorTopicYN="N">ischemic stroke</Keyword><Keyword MajorTopicYN="N">neurorehabilitation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>25</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35328506</ArticleId><ArticleId IdType="pmc">PMC8949282</ArticleId><ArticleId IdType="doi">10.3390/ijms23063085</ArticleId><ArticleId IdType="pii">ijms23063085</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yaghi S., Ishida K., Torres J., Mac Grory B., Raz E., Humbert K., Henninger N., Trivedi T., Lillemoe K., Alam S., et al. SARS-CoV-2 and Stroke in a New York Healthcare System. Stroke. 2020;51:2002&#x2013;2011. doi: 10.1161/STROKEAHA.120.030335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.120.030335</ArticleId><ArticleId IdType="pmc">PMC7258764</ArticleId><ArticleId IdType="pubmed">32432996</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., Song H. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet. 2020;395:565&#x2013;574. doi: 10.1016/S0140-6736(20)30251-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30251-8</ArticleId><ArticleId IdType="pmc">PMC7159086</ArticleId><ArticleId IdType="pubmed">32007145</ArticleId></ArticleIdList></Reference><Reference><Citation>Najjar S., Najjar A., Chong D.J., Pramanik B.K., Kirsch C., Kuzniecky R.I., Pacia S.V., Azhar S. Central nervous system complications associated with SARS-CoV-2 infection: Integrative concepts of pathophysiology and case reports. J. Neuroinflamm. 2020;17:231. doi: 10.1186/s12974-020-01896-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01896-0</ArticleId><ArticleId IdType="pmc">PMC7406702</ArticleId><ArticleId IdType="pubmed">32758257</ArticleId></ArticleIdList></Reference><Reference><Citation>Hess D.C., Eldahshan W., Rutkowski E. COVID-19-Related Stroke. Transl. Stroke Res. 2020;11:322&#x2013;325. doi: 10.1007/s12975-020-00818-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12975-020-00818-9</ArticleId><ArticleId IdType="pmc">PMC7202903</ArticleId><ArticleId IdType="pubmed">32378030</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeratne T., Crewther S.G., Sales C., Karimi L. COVID-19 pathophysiology predicts that ischemic stroke occurrence is an expectation, not an exception&#x2014;A systematic review. Front. Neurol. 2020;11:1031. doi: 10.3389/fneur.2020.01031.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.01031</ArticleId><ArticleId IdType="pmc">PMC7876298</ArticleId><ArticleId IdType="pubmed">33584506</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyrouti R., Adams M.E., Benjamin L., Cohen H., Farmer S.F., Goh Y.Y., Humphries F., J&#xe4;ger H.R., Losseff N.A., Peryy R.J., et al. Characteristics of ischaemic stroke associated with COVID-19. J. Neurol. Neurosurg. Psychiatry. 2020;91:889&#x2013;891. doi: 10.1136/jnnp-2020-323586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-323586</ArticleId><ArticleId IdType="pmc">PMC7231545</ArticleId><ArticleId IdType="pubmed">32354768</ArticleId></ArticleIdList></Reference><Reference><Citation>Belani P., Schefflein J., Kihira S., Rigney B., Delman B.N., Mahmoudi K., Mocco J., Majidi S., Yeckly J., Lefton D., et al. COVID-19 is an independent risk factor for acute ischemic stroke. Am. J. Neuroradiol. 2020;41:1361&#x2013;1364. doi: 10.3174/ajnr.A6650.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A6650</ArticleId><ArticleId IdType="pmc">PMC7658882</ArticleId><ArticleId IdType="pubmed">32586968</ArticleId></ArticleIdList></Reference><Reference><Citation>Dogra S., Jain R., Cao M., Bilaloglu S., Zagzag D., Hochman S., Lewis A., Melmed K., Hochman K., Horwitz L., et al. Hemorrhagic stroke and anticoagulation in COVID-19. J. Stroke Cerebrovasc. Dis. 2020;29:104984. doi: 10.1016/j.jstrokecerebrovasdis.2020.104984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2020.104984</ArticleId><ArticleId IdType="pmc">PMC7245254</ArticleId><ArticleId IdType="pubmed">32689588</ArticleId></ArticleIdList></Reference><Reference><Citation>Merkler A.E., Parikh N.S., Mir S., Gupta A., Kamel H., Lin E., Lantos J., Schenck E.J., Goyal P., Brice S.S., et al. Risk of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza. JAMA Neurol. 2020;77:1366&#x2013;1372. doi: 10.1001/jamaneurol.2020.2730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.2730</ArticleId><ArticleId IdType="pmc">PMC7333175</ArticleId><ArticleId IdType="pubmed">32614385</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Sharif E., Strianese D., AlMadhi N.H., D&#x2019;Aponte A., dell&#x2019;Omo R., DiBenedetto R., Costagliola C. Ocular tropism of coronavirus (CoVs): A comparison of the interaction between the animal-to-human transmitted coronaviruses (SARS-CoV-1, SARS-CoV-2, MERS-CoV, CoV-229E, NL63, OC43, HKU1) and the eye. Int. Ophthalmol. 2021;41:349&#x2013;362. doi: 10.1007/s10792-020-01575-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10792-020-01575-2</ArticleId><ArticleId IdType="pmc">PMC7471531</ArticleId><ArticleId IdType="pubmed">32880786</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitmore H., Kim L. Understanding the Role of Blood Vessels in the Neurologic Manifestations of Coronavirus Disease 2019 (COVID-19) Am. J. Pathol. 2021;191:1946&#x2013;1954. doi: 10.1016/j.ajpath.2021.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2021.04.017</ArticleId><ArticleId IdType="pmc">PMC8193973</ArticleId><ArticleId IdType="pubmed">34126084</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Y., Wunderink R.G. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology. 2018;23:130&#x2013;137. doi: 10.1111/resp.13196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/resp.13196</ArticleId><ArticleId IdType="pmc">PMC7169239</ArticleId><ArticleId IdType="pubmed">29052924</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239&#x2013;1242. doi: 10.1001/jama.2020.2648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., Nair N., Mahajan S., Sehrawat T.S., Bikdeli B., Ahluwalia N., Ausiello J.C., Wan E.Y., et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020;26:1017&#x2013;1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Zhou X., Luo J., et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A., Bernabei R., Landi F., Gemelli Against COVID-19 Post-Acute Care Study Group Persistent symptoms in patients after acute COVID-19. J. Am. Med. Assoc. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>De Wit E., Van Doremalen N., Falzarano D., Munster V.J. SARS and MERS: Recent insights into emerging coronaviruses. Nat. Rev. Microbiol. 2016;14:523&#x2013;534. doi: 10.1038/nrmicro.2016.81.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro.2016.81</ArticleId><ArticleId IdType="pmc">PMC7097822</ArticleId><ArticleId IdType="pubmed">27344959</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M.W., Kim S.S., Lindsell C.J., Rose E.B., Shapiro N.I., Files D.C., Gibbs K.W., Erickson H.L., Steingrub J.S., Smithline H.A., et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network&#x2014;United States, March&#x2013;June 2020. Morb. Mortal. Wkly Rep. 2020;69:993&#x2013;998. doi: 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Sungnak W., Huang N., B&#xe9;cavin C., Berg M., Queen R., Litvinukova M., Talavera-L&#xf3;pez C., Maatz H., Reichart D., Sampaziotis F., et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat. Med. 2020;26:681&#x2013;687. doi: 10.1038/s41591-020-0868-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0868-6</ArticleId><ArticleId IdType="pmc">PMC8637938</ArticleId><ArticleId IdType="pubmed">32327758</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 2020;18:844&#x2013;847. doi: 10.1111/jth.14768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14768</ArticleId><ArticleId IdType="pmc">PMC7166509</ArticleId><ArticleId IdType="pubmed">32073213</ArticleId></ArticleIdList></Reference><Reference><Citation>Channappanavar R., Perlman S. Pathogenic human coronavirus infections: Causes and consequences of cytokine storm and immunopathology. Semin. Immunopathol. 2017;39:529&#x2013;539. doi: 10.1007/s00281-017-0629-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-017-0629-x</ArticleId><ArticleId IdType="pmc">PMC7079893</ArticleId><ArticleId IdType="pubmed">28466096</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed H., Patel K., Greenwood D.C., Halpin S., Lewthwaite P., Salawu A., Eyre L., Breen A., O&#x2019;Connor R., Jones A., et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis. J. Rehabil. Med. 2020;52:jrm00063. doi: 10.2340/16501977-2694.</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/16501977-2694</ArticleId><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee A.M., Wong J.G.W.S., McAlonan G.M., Cheung V., CHeing C., Sham P.C., Chu C.-M., Wong P.-C., Tsang K.W.T., Chua S.E. Stress and psychological distress among SARS survivors 1 year after the outbreak. Can. J. Psychiatry. 2007;52:233&#x2013;240. doi: 10.1177/070674370705200405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/070674370705200405</ArticleId><ArticleId IdType="pubmed">17500304</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.H., Shin H.-S., Park H.Y., Kim J.L., Lee J.J., Lee H., Won S.-D., Han W. Depression as a mediator of chronic fatigue and post-traumatic stress symptoms in Middle East respiratory syndrome survivors. Psychiatry Investig. 2019;16:59&#x2013;64. doi: 10.30773/pi.2018.10.22.3.</Citation><ArticleIdList><ArticleId IdType="doi">10.30773/pi.2018.10.22.3</ArticleId><ArticleId IdType="pmc">PMC6354037</ArticleId><ArticleId IdType="pubmed">30605995</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam M.H., Wing Y.-K., Yu M.W.-M., Leung C.-M., Ma R.C.-W., Kong A.P.S., So W.Y., Fong S.Y.-Y., Lam S.-P. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: Long-term follow-up. Arch. Intern. Med. 2009;169:2142&#x2013;2147. doi: 10.1001/archinternmed.2009.384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2009.384</ArticleId><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta S.D., Talwar A., Lee J.T. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: Illness beyond acute infection and public health implications. J. Am. Med. Assoc. 2020;324:2251&#x2013;2252. doi: 10.1001/jama.2020.22717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22717</ArticleId><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Kampen J.J.A., van de Vijver D.A.M.C., Fraaij P.L.A., Haagmans B.L., Lamers M.M., Okba N., van den Akker J.P.C., Endemen H., Gommers D.A.M.P.J., Cornelissen J.J., et al. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19) Nat. Commun. 2021;12:267. doi: 10.1038/s41467-020-20568-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20568-4</ArticleId><ArticleId IdType="pmc">PMC7801729</ArticleId><ArticleId IdType="pubmed">33431879</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nature Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W., Hillman T., Playford E.D., Hishmeh L. Managing the long-term effects of COVID-19: Summary of NICE, SIGN, and RCGP rapid guideline. Brit. Med. J. 2021;372:n136. doi: 10.1136/bmj.n136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Karim S., Karim Q. Omicron SARS-CoV-2 variant: A new chapter in the COVID-19 pandemic. Lancet. 2021;398:2126&#x2013;2128. doi: 10.1016/S0140-6736(21)02758-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02758-6</ArticleId><ArticleId IdType="pmc">PMC8640673</ArticleId><ArticleId IdType="pubmed">34871545</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham M., Sudre C., May A., Antonelli M., Murray B., Varsavsky T., Kl&#xe4;ser K., Canas L.S., Molteni E., Modat M., et al. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: An ecological study. Lancet Public Health. 2021;6:e335&#x2013;e345. doi: 10.1016/S2468-2667(21)00055-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(21)00055-4</ArticleId><ArticleId IdType="pmc">PMC8041365</ArticleId><ArticleId IdType="pubmed">33857453</ArticleId></ArticleIdList></Reference><Reference><Citation>Che Mohd Nassir C., Hashim S., Wong K., Abdul Halim S., Idris N., Jayabalan N., Jayabalan N., Guo D., Mustapha M. COVID-19 Infection and Circulating Microparticles&#x2014;Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease. Mol. Neurobiol. 2021;58:4188&#x2013;4215. doi: 10.1007/s12035-021-02457-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02457-z</ArticleId><ArticleId IdType="pmc">PMC8235918</ArticleId><ArticleId IdType="pubmed">34176095</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakeri A., Jadhav A., Sullenger B., Nimjee S. Ischemic stroke in COVID-19-positive patients: An overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist. J. NeuroInterv. Surg. 2021;13:202&#x2013;206. doi: 10.1136/neurintsurg-2020-016794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/neurintsurg-2020-016794</ArticleId><ArticleId IdType="pubmed">33298508</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqi H.K., Libby P., Ridker P.M. COVID-19&#x2014;A vascular disease. Trends Cardiovasc. Med. 2021;31:1&#x2013;5. doi: 10.1016/j.tcm.2020.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2020.10.005</ArticleId><ArticleId IdType="pmc">PMC7556303</ArticleId><ArticleId IdType="pubmed">33068723</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P., L&#xfc;scher T. COVID-19 is, in the end, an endothelial disease. Eur. Heart J. 2020;41:3038&#x2013;3044. doi: 10.1093/eurheartj/ehaa623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa623</ArticleId><ArticleId IdType="pmc">PMC7470753</ArticleId><ArticleId IdType="pubmed">32882706</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingstone T., Taylor A.K., O&#x2019;Donnell C.A., Atherton H., Blane D.N., Chew-Graham C.A. Finding the &#x2018;right&#x2019; GP: A qualitative study of the experiences of people with long-COVID. BJGP Open. 2020;4:bjgpopen20X101143. doi: 10.3399/bjgpopen20X101143.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgpopen20X101143</ArticleId><ArticleId IdType="pmc">PMC7880173</ArticleId><ArticleId IdType="pubmed">33051223</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz Y.M.J., Van Herck M., Delbressine J.M., Vaes A.W., Meys R., Machado F.V.C., Houben-Wilke S., Burtin C., Posthuma R., Franssen F.M.E., et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: The post-COVID-19 syndrome? ERJ Open Res. 2020;6:00542&#x2013;02020. doi: 10.1183/23120541.00542-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Ntaios G., Michel P., Georgiopoulos G., Guo Y., Li W., Xiong J., Calleja P., Ostos F., Gonz&#xe1;lez-Ortega G., Fuentes B., et al. Characteristics and outcomes in patients with COVID-19 and acute ischemic stroke. Stroke. 2020;51:e254&#x2013;e258. doi: 10.1161/STROKEAHA.120.031208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.120.031208</ArticleId><ArticleId IdType="pmc">PMC7359900</ArticleId><ArticleId IdType="pubmed">32787707</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashrafi F., Zali A., Ommi D., Salari M., Fatemi A., Arab-Ahmadi M., Behnam B., Azhideh A., Vahidi M., Yousef-Asl M., et al. COVID-19-related strokes in adults below 55 years of age: A case series. Neurol. Sci. 2020;41:1985&#x2013;1989. doi: 10.1007/s10072-020-04521-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04521-3</ArticleId><ArticleId IdType="pmc">PMC7311861</ArticleId><ArticleId IdType="pubmed">32583169</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Zheng Y., Gou X., Pu K., Chen Z., Guo Q., Ji R., Wang H., Wang Y., Zhou Y. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: A systematic review and meta-analysis. Int. J. Infect. Dis. 2020;94:91&#x2013;95. doi: 10.1016/j.ijid.2020.03.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.03.017</ArticleId><ArticleId IdType="pmc">PMC7194638</ArticleId><ArticleId IdType="pubmed">32173574</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu T.M., Seet Y.H., Koh J.S., Tham C.H., Chiew H.J., De Leon J.A., Chua C.Y.K., Hui A.C.-F., Tan S.S.Y., Vasoo S.S., et al. Acute ischemic stroke during the convalescent phase of asymptomatic COVID-19 infection in men. JAMA Open. 2021;4:e217498. doi: 10.1001/jamanetworkopen.2021.7498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.7498</ArticleId><ArticleId IdType="pmc">PMC8063067</ArticleId><ArticleId IdType="pubmed">33885771</ArticleId></ArticleIdList></Reference><Reference><Citation>Spence J.D., de Freitas G.R., Pettigrew L.C., Ay H., Liebeskind D.S., Kase C.S., Del Brutto O.H., Hankey G.J., Venketasubramanian N. Mechanisms of stroke in COVID-19. Cerebrovasc. Dis. 2020;49:451&#x2013;458. doi: 10.1159/000509581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000509581</ArticleId><ArticleId IdType="pmc">PMC7445374</ArticleId><ArticleId IdType="pubmed">32690850</ArticleId></ArticleIdList></Reference><Reference><Citation>Ntaios G., Pearce L.A., Veltkamp R., Sharma M., Kasner S.E., Korompoki E., Milionis H., Mundl H., Berkowitzt S.D., Connolly S.J., et al. Potential embolic sources and outcomes in embolic stroke of undetermined source in the NAVIGATE-ESUS trial. Stroke. 2020;51:1797&#x2013;1804. doi: 10.1161/STROKEAHA.119.028669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.119.028669</ArticleId><ArticleId IdType="pubmed">32295509</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahjouei S., Naderi S., Li J., Khan A., Chaudhary D., Farahmand G., Male S., Griessenauer C., Sabra M., Mondello S., et al. Risk of stroke in hospitalized SARS-CoV-2 infected patients: A multinational study. EBioMedicine. 2020;59:102939. doi: 10.1016/j.ebiom.2020.102939.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102939</ArticleId><ArticleId IdType="pmc">PMC7429203</ArticleId><ArticleId IdType="pubmed">32818804</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeratne T., Crewther S. COVID-19 and long-term neurological problems: Challenges ahead with post-COVID-19 Neurological Syndrome. Aust. J. Gen. Pract. 2021;50((Suppl. 43)):1&#x2013;5. doi: 10.31128/AJGP-COVID-43.</Citation><ArticleIdList><ArticleId IdType="doi">10.31128/AJGP-COVID-43</ArticleId><ArticleId IdType="pubmed">33543150</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen V.A., Crewther S.G., Howells D.W., Wijeratne T., Ma H., Hankey G.J., Davis S., Donnan G.A., Carey L.M. Acute routine leukocyte and neutrophil counts are predictive of poststroke recovery at 3 and12 months poststroke: An exploratory study. Neurorehabil. Neural Repair. 2020;34:844&#x2013;855. doi: 10.1177/1545968320948607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1545968320948607</ArticleId><ArticleId IdType="pubmed">32940147</ArticleId></ArticleIdList></Reference><Reference><Citation>Racine N., McArthur B.A., Cooke J.E., Eirich R., Zhu J., Madigan S. Global prevalence of depressive and anxiety symptoms in children during COVID-10: A meta-analysis. JAMA Paediatr. 2021;175:1142&#x2013;1150. doi: 10.1001/jamapediatrics.2021.2482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2021.2482</ArticleId><ArticleId IdType="pmc">PMC8353576</ArticleId><ArticleId IdType="pubmed">34369987</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatti C., Blom J.M., Rigillo G., Alboni S., Zizzi F., Torta R., Brunello N., Tascedda F. Disease induced neuroinflammation and depression. CNS Neurol. Disord. Drug Targets. 2016;15:414&#x2013;433. doi: 10.2174/1871527315666160321104749.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871527315666160321104749</ArticleId><ArticleId IdType="pubmed">26996176</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J., Fan J., Wu F., Huang Q., Guo M., Lv M., Han J., Duan L., Hu G., Chen L., et al. The ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Pleiotropic Roles in Cancer. Front. Physiol. 2017;8:276. doi: 10.3389/fphys.2017.00276.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2017.00276</ArticleId><ArticleId IdType="pmc">PMC5420593</ArticleId><ArticleId IdType="pubmed">28533754</ArticleId></ArticleIdList></Reference><Reference><Citation>Mecca A.P., Regenhardt R.W., O&#x2019;Connor T.E., Joseph J.P., Raizada M.K., Katovich M.J., Sumners C. Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke. Exp. Physiol. 2011;96:1084&#x2013;1096. doi: 10.1113/expphysiol.2011.058578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/expphysiol.2011.058578</ArticleId><ArticleId IdType="pmc">PMC3210510</ArticleId><ArticleId IdType="pubmed">21685445</ArticleId></ArticleIdList></Reference><Reference><Citation>Sodhi C.P., Wohlford-Lenane C., Yamaguchi Y., Prindle T., Fulton W.B., Wang S., McCray P.B., Jr., Chappell M., Hackam D.J., Jia H. Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration. Am. J. Physiol. Lung Cell Mol. Physiol. 2018;314:L17&#x2013;L31. doi: 10.1152/ajplung.00498.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00498.2016</ArticleId><ArticleId IdType="pmc">PMC5866432</ArticleId><ArticleId IdType="pubmed">28935640</ArticleId></ArticleIdList></Reference><Reference><Citation>Montalvan V., Lee J., Bueso T., Toledo J.D., Rivas K. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review. Clin. Neurol. Neurosurg. 2020;194:105921. doi: 10.1016/j.clineuro.2020.105921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2020.105921</ArticleId><ArticleId IdType="pmc">PMC7227498</ArticleId><ArticleId IdType="pubmed">32422545</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig A.M., Khaleeq A., Ali U., Syeda H. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem. Neurosci. 2020;11:995&#x2013;998. doi: 10.1021/acschemneuro.0c00122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00122</ArticleId><ArticleId IdType="pubmed">32167747</ArticleId></ArticleIdList></Reference><Reference><Citation>Netland J., Meyerholz D.K., Moore S., Cassell M., Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J. Virol. 2008;82:7264&#x2013;7275. doi: 10.1128/JVI.00737-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00737-08</ArticleId><ArticleId IdType="pmc">PMC2493326</ArticleId><ArticleId IdType="pubmed">18495771</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennion D.M., Haltigan E., Regenharrdt W.W., Steckelings U.M., Summers C. Neuroprotective mechanisms of the ACE2-angiotensin-(1-7)-Mas axis in stroke. Curr. Hypertens Rep. 2015;17:3. doi: 10.1007/s11906-014-0512-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11906-014-0512-2</ArticleId><ArticleId IdType="pmc">PMC4378688</ArticleId><ArticleId IdType="pubmed">25620630</ArticleId></ArticleIdList></Reference><Reference><Citation>Regenhardt R.W., Bennion D.M., Sumners C. Cerebroprotective action of angiotensin peptides in stroke. Clin. Sci. 2014;126:195&#x2013;205. doi: 10.1042/CS20130324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20130324</ArticleId><ArticleId IdType="pmc">PMC7453725</ArticleId><ArticleId IdType="pubmed">24102099</ArticleId></ArticleIdList></Reference><Reference><Citation>Kagiyama T., Kagiyama S., Phillips M.I. Expression of angiotensin type 1 and 2 receptors in brain after transient middle cerebral artery occlusion in rats. Regul. Pept. 2003;110:241&#x2013;247. doi: 10.1016/S0167-0115(02)00223-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0167-0115(02)00223-9</ArticleId><ArticleId IdType="pubmed">12573806</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang A.Y., Li F.C.H., Huang C.-H., Wu J.C.C., Dai K.-Y., Chen C.-H., Li S.-H., Su C.-H., Wu R.-W. Interplay between brain stem angiotensins and monocyte chemoattractant protein-1 as a novel mechanism for pressor response after ischemic stroke. Neurobiol. Dis. 2014;71:292&#x2013;304. doi: 10.1016/j.nbd.2014.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.08.005</ArticleId><ArticleId IdType="pubmed">25131447</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J., Jiang T., Wu L., Gao L., Wang Y., Zhou F., Zhang S., Zhang Y. The expression of angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas receptor axis are upregulated after acute cerebral ischemic stroke in rats. Neuropeptides. 2013;47:289&#x2013;295. doi: 10.1016/j.npep.2013.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.npep.2013.09.002</ArticleId><ArticleId IdType="pubmed">24090950</ArticleId></ArticleIdList></Reference><Reference><Citation>Mogi M., Kawajiri M., Tsukuda K., Matsumoto S., Yamada T., Horiuchi M. Serum levels of renin-angiotensin system components in acute stroke patients. Geriatr. Gerontol. Int. 2014;14:793&#x2013;798. doi: 10.1111/ggi.12167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ggi.12167</ArticleId><ArticleId IdType="pubmed">24279732</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu P., Sriramula S., Lazartigues E. ACE2/ANG-(1-7)/Mas pathway in the brain: The axis of good. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011;300:R804-17. doi: 10.1152/ajpregu.00222.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.00222.2010</ArticleId><ArticleId IdType="pmc">PMC3075080</ArticleId><ArticleId IdType="pubmed">21178125</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J.J., Li G., Chen S., Bihl J., Buck J., Zhu Y., Xia H., Lazartigues E., Chen Y., Olson J.E. Activation of the ACE2/Ang-(1 7)/Mas pathway reduces oxygen glucose deprivation-induced tissue swelling, ROS production, and cell death in mouse brain with angiotensin II overproduction. Neuroscience. 2014;273:39&#x2013;51. doi: 10.1016/j.neuroscience.2014.04.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2014.04.060</ArticleId><ArticleId IdType="pmc">PMC4159741</ArticleId><ArticleId IdType="pubmed">24814023</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Evans M.A., Chu H.X., Kim H.A., Widdop R.E., Drummond G.R., Sobey C.G. Effect of a Selective Mas Receptor Agonist in Cerebral Ischemia In Vitro and In Vivo. PLoS ONE. 2015;10:e0142087. doi: 10.1371/journal.pone.0142087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0142087</ArticleId><ArticleId IdType="pmc">PMC4634944</ArticleId><ArticleId IdType="pubmed">26540167</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuipers A., Moll G.N., Levy A., Krakovsky M., Franklin R. Cyclic angiotensin-(1-7) contributes to rehabilitation of animal performance in a rat model of cerebral stroke. Peptides. 2020;123:170193. doi: 10.1016/j.peptides.2019.170193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.peptides.2019.170193</ArticleId><ArticleId IdType="pubmed">31704212</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu D., Zhao B., Ye Y., Li Y., Zhang Y., Xiong X., Gu L. Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke. J. Neuroinflamm. 2021;18:123. doi: 10.1186/s12974-021-02137-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02137-8</ArticleId><ArticleId IdType="pmc">PMC8166383</ArticleId><ArticleId IdType="pubmed">34059091</ArticleId></ArticleIdList></Reference><Reference><Citation>Tschopp J., Schroder K. NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production? Nat. Rev. Immunol. 2010;10:210&#x2013;215. doi: 10.1038/nri2725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2725</ArticleId><ArticleId IdType="pubmed">20168318</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutterwala F.S., Ogura Y., Szczepanik M., Lara-Tejero M., Lichtenberger G.S., Grant E.P., Bertin J., Coyle A.J., Galan J.E., Askenase P.W., et al. Critical Role for NALP3/CIAS1/Cryopyrin in Innate and Adaptive Immunity through Its Regulation of Caspase-1. Immunity. 2006;24:317&#x2013;327. doi: 10.1016/j.immuni.2006.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2006.02.004</ArticleId><ArticleId IdType="pubmed">16546100</ArticleId></ArticleIdList></Reference><Reference><Citation>Agostini L., Martinon F., Burns K., McDermott M.F., Hawkins P.N., Tschopp J. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity. 2004;20:319&#x2013;325. doi: 10.1016/S1074-7613(04)00046-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1074-7613(04)00046-9</ArticleId><ArticleId IdType="pubmed">15030775</ArticleId></ArticleIdList></Reference><Reference><Citation>Broz P., von Moltke J., Jones J.W., Vance R.E., Monack D.M. Differential requirement for CASPASE-1 autoproteolysis in pathogen-induced cell death and cytokine processing. Cell Host Microbe. 2010;8:471&#x2013;483. doi: 10.1016/j.chom.2010.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2010.11.007</ArticleId><ArticleId IdType="pmc">PMC3016200</ArticleId><ArticleId IdType="pubmed">21147462</ArticleId></ArticleIdList></Reference><Reference><Citation>Franchi L., Eigenbrod T., Mu&#xf1;oz-Planillo R., Nu&#xf1;ez G. The inflammasome: A caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat. Immunol. 2009;10:241&#x2013;247. doi: 10.1038/ni.1703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1703</ArticleId><ArticleId IdType="pmc">PMC2820724</ArticleId><ArticleId IdType="pubmed">19221555</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y.J., Zheng L., Hu Y.W., Wang Q. Pyroptosis and its relationship to atherosclerosis. Clin. Chim. Acta. 2018;476:28&#x2013;37. doi: 10.1016/j.cca.2017.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2017.11.005</ArticleId><ArticleId IdType="pubmed">29129476</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson K.V., Deng M., Ting J.P. The NLRP3 inflammasome: Molecular activation and regulation to therapeutics. Nat. Rev. Immunol. 2019;19:477&#x2013;489. doi: 10.1038/s41577-019-0165-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-019-0165-0</ArticleId><ArticleId IdType="pmc">PMC7807242</ArticleId><ArticleId IdType="pubmed">31036962</ArticleId></ArticleIdList></Reference><Reference><Citation>Bano D., Young K.W., Guerin C.J., Lefeuvre R., Rothwell N.J., Naldini L., Rizzuto R., Carafoli E., Nicotera P. Cleavage of the plasma membrane Na+/Ca2+ exchanger in excitotoxicity. Cell. 2005;120:275&#x2013;285. doi: 10.1016/j.cell.2004.11.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2004.11.049</ArticleId><ArticleId IdType="pubmed">15680332</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou R., Tardivel A., Thorens B., Choi I., Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 2010;11:136&#x2013;140. doi: 10.1038/ni.1831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1831</ArticleId><ArticleId IdType="pubmed">20023662</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami T., Ockinger J., Yu J., Byles V., McColl A., Hofer A.M., Horng T. Critical role for calcium mobilization in activation of the NLRP3 inflammasome. Proc. Natl. Acad. Sci. USA. 2012;109:11282&#x2013;11287. doi: 10.1073/pnas.1117765109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1117765109</ArticleId><ArticleId IdType="pmc">PMC3396518</ArticleId><ArticleId IdType="pubmed">22733741</ArticleId></ArticleIdList></Reference><Reference><Citation>Turrens J.F. Mitochondrial formation of reactive oxygen species. Pt 2J. Physiol. 2003;552:335&#x2013;344. doi: 10.1113/jphysiol.2003.049478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2003.049478</ArticleId><ArticleId IdType="pmc">PMC2343396</ArticleId><ArticleId IdType="pubmed">14561818</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochoa C.D., Wu R.F., Terada L.S. ROS signaling and ER stress in cardiovascular disease. Mol. Asp. Med. 2018;63:18&#x2013;29. doi: 10.1016/j.mam.2018.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mam.2018.03.002</ArticleId><ArticleId IdType="pmc">PMC6139279</ArticleId><ArticleId IdType="pubmed">29559224</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman J.R., Lackner L.L., West M., DiBenedetto J.R., Nunnari J., Voeltz G.K. ER tubules mark sites of mitochondrial division. Science. 2011;334:358&#x2013;362. doi: 10.1126/science.1207385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1207385</ArticleId><ArticleId IdType="pmc">PMC3366560</ArticleId><ArticleId IdType="pubmed">21885730</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimada K., Crother T.R., Karlin J., Dagvadorj J., Chiba N., Chen S., Ramanujan K., Wolf A.J., Vergnes L., Ojcius D.M., et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity. 2012;36:401&#x2013;414. doi: 10.1016/j.immuni.2012.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2012.01.009</ArticleId><ArticleId IdType="pmc">PMC3312986</ArticleId><ArticleId IdType="pubmed">22342844</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu B., Nakamura T., Inouye K., Li J., Tang Y., Lundb&#xe4;ck P., Valdes-Ferrer S.I., Olofsson P.S., Kalb T., Roth J., et al. Novel role of PKR in inflammasome activation and HMGB1 release. Nature. 2012;488:670&#x2013;674. doi: 10.1038/nature11290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11290</ArticleId><ArticleId IdType="pmc">PMC4163918</ArticleId><ArticleId IdType="pubmed">22801494</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasoohi S., Ismael S., Ishrat T. Thioredoxin-interacting protein (TXNIP) in Cerebrovascular and neurodegenerative diseases: Regulation and implication. Mol. Neurobiol. 2018;55:7900&#x2013;7920. doi: 10.1007/s12035-018-0917-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-0917-z</ArticleId><ArticleId IdType="pmc">PMC6388721</ArticleId><ArticleId IdType="pubmed">29488135</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv H., Liu Q., Wen Z., Feng H., Deng X., Ci X. Xanthohumol ameliorates lipopolysaccharide (LPS)-induced acute lung injury via induction of AMPK/GSK3&#x3b2;-Nrf2 signal axis. Redox Biol. 2017;12:311&#x2013;324. doi: 10.1016/j.redox.2017.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2017.03.001</ArticleId><ArticleId IdType="pmc">PMC5345976</ArticleId><ArticleId IdType="pubmed">28285192</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P., He F.F., Tang H., Lei C.T., Chen S., Meng X.F., Su H., Zhang C. NADPH oxidaseinduced NALP3 inflammasome activation is driven by thioredoxininteracting protein which contributes to podocyte injury in hyperglycemia. J. Diabetes Res. 2015;2015:504761. doi: 10.1155/2015/504761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/504761</ArticleId><ArticleId IdType="pmc">PMC4365330</ArticleId><ArticleId IdType="pubmed">25834832</ArticleId></ArticleIdList></Reference><Reference><Citation>Oslowski C.M., Hara T., O&#x2019;Sullivan-Murphy B., Kanekura K., Lu S., Hara M., Ishigaki S., Zhu L.J., Hayashi E., Hui S.T., et al. Thioredoxin-interacting protein mediates ER stress-induced &#x3b2; cell death through initiation of the inflammasome. Cell Metab. 2012;16:265&#x2013;273. doi: 10.1016/j.cmet.2012.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2012.07.005</ArticleId><ArticleId IdType="pmc">PMC3418541</ArticleId><ArticleId IdType="pubmed">22883234</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilinc M., G&#xfc;rsoy-Ozdemir Y., G&#xfc;rer G., Erdener S.E., Erdemli E., Can A., Dalkara T. Lysosomal rupture, necroapoptotic interactions and potential crosstalk between cysteine proteases in neurons shortly after focal ischemia. Neurobiol. Dis. 2010;40:293&#x2013;302. doi: 10.1016/j.nbd.2010.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2010.06.003</ArticleId><ArticleId IdType="pubmed">20600913</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu H.J., Song M. Disrupted Ionic Homeostasis in Ischemic Stroke and New Therapeutic Targets. J. Stroke Cerebrovasc. Dis. 2017;26:2706&#x2013;2719. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2017.09.011</ArticleId><ArticleId IdType="pubmed">29054733</ArticleId></ArticleIdList></Reference><Reference><Citation>Kono H., Kimura Y., Latz E. Inflammasome activation in response to dead cells and their metabolites. Curr. Opin. Immunol. 2014;30:91&#x2013;98. doi: 10.1016/j.coi.2014.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2014.09.001</ArticleId><ArticleId IdType="pubmed">25282339</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J., Gao W., Shao F. Pyroptosis: Gasdermin-mediated programmed necrotic cell death. Trends Biochem. Sci. 2017;42:245&#x2013;254. doi: 10.1016/j.tibs.2016.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2016.10.004</ArticleId><ArticleId IdType="pubmed">27932073</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D., Qian J., Zhang P., Li H., Shen H., Li X., Chen G. Gasdermin D serves as a key executioner of pyroptosis in experimental cerebral ischemia and reperfusion model both in vivo and in vitro. J. Neurosci. Res. 2019;97:645&#x2013;660. doi: 10.1002/jnr.24385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.24385</ArticleId><ArticleId IdType="pubmed">30600840</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinon F., Mayor A., Tschopp J. The inflammasomes: Guardians of the body. Annu. Rev. Immunol. 2009;27:229&#x2013;265. doi: 10.1146/annurev.immunol.021908.132715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.021908.132715</ArticleId><ArticleId IdType="pubmed">19302040</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Hao J.H., Yao D., Li R., Li X.F., Yu Z.Y., Luo X., Liu X.-H., Wang M.-H., Wang W. Caspase-1 inhibition prevents neuronal death by targeting the canonical inflammasome pathway of pyroptosis in a murine model of cerebral ischemia. CNS Neurosci. Ther. 2020;26:925&#x2013;939. doi: 10.1111/cns.13384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13384</ArticleId><ArticleId IdType="pmc">PMC7415206</ArticleId><ArticleId IdType="pubmed">32343048</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye X., Shen T., Hu J., Zhang L., Zhang Y., Bao L., Cui C., Jin G., Zan K., Zhang Z., et al. Purinergic 2X7 receptor/NLRP3 pathway triggers neuronal apoptosis after ischemic stroke in the mouse. Exp. Neurol. 2017;292:46&#x2013;55. doi: 10.1016/j.expneurol.2017.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2017.03.002</ArticleId><ArticleId IdType="pubmed">28274860</ArticleId></ArticleIdList></Reference><Reference><Citation>Murta V., Villarreal A., Ramos A.J. Severe acute respiratory syndrome coronavirus 2 impact on the central nervous system: Are astrocytes and microglia main players or merely bystanders? ASN Neuro. 2020;12:1759091420954960. doi: 10.1177/1759091420954960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1759091420954960</ArticleId><ArticleId IdType="pmc">PMC7476346</ArticleId><ArticleId IdType="pubmed">32878468</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro D.E., Oliveira-Giacomelli &#xc1;., Glaser T., Arnaud-Sampaio V.F., Andrejew R., Dieckmann L., Baranova J., Lameu C., Ratajczak M.Z., Ulrich H. Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology. Mol. Psychiatry. 2020;26:1044&#x2013;1059. doi: 10.1038/s41380-020-00965-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-020-00965-3</ArticleId><ArticleId IdType="pmc">PMC7738776</ArticleId><ArticleId IdType="pubmed">33328588</ArticleId></ArticleIdList></Reference><Reference><Citation>Paniri A., Akhavan-Niaki H. Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation. Life Sci. 2020;257:118114. doi: 10.1016/j.lfs.2020.118114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.118114</ArticleId><ArticleId IdType="pmc">PMC7368418</ArticleId><ArticleId IdType="pubmed">32693241</ArticleId></ArticleIdList></Reference><Reference><Citation>Magro C., Mulvey J.J., Berlin D., Nuovo G., Laurence J.J.T.R. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Transl. Res. 2020;220:1&#x2013;13. doi: 10.1016/j.trsl.2020.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2020.04.007</ArticleId><ArticleId IdType="pmc">PMC7158248</ArticleId><ArticleId IdType="pubmed">32299776</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou X.Q., Qin J.L., Zheng X.X., Wang L., Yang S.T., Gao Y.W., Xia X.Z.H. Potential role of high-mobility group box 1 protein in the pathogenesis of influenza H5N1 virus infection. Acta Virol. 2014;58:69&#x2013;75. doi: 10.4149/av_2014_01_69.</Citation><ArticleIdList><ArticleId IdType="doi">10.4149/av_2014_01_69</ArticleId><ArticleId IdType="pubmed">24717031</ArticleId></ArticleIdList></Reference><Reference><Citation>Krakauer J.W., Carmichael S.T., Corbett D., Wittenberg G.F. Getting neurorehabilitation right: What can be learned from animal models? Neurorehabil. Neural Repair. 2012;26:923&#x2013;931. doi: 10.1177/1545968312440745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1545968312440745</ArticleId><ArticleId IdType="pmc">PMC4554531</ArticleId><ArticleId IdType="pubmed">22466792</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeiler S.R., Krakauer J.W. The interaction between training and plasticity in the poststroke brain. Curr. Opin. Neurol. 2013;26:609&#x2013;616. doi: 10.1097/WCO.0000000000000025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000025</ArticleId><ArticleId IdType="pmc">PMC4012223</ArticleId><ArticleId IdType="pubmed">24136129</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirillo C., Brihmat N., Castel-Lacanal E., Le Friec A., Barbieux-Guillot M., Raposo N., Pariente J., Viguier A., Simonetta-Moreau M., Albucher J.F., et al. Post-stroke remodeling processes in animal models and humans. J. Cereb. Blood Flow Metab. 2020;40:3&#x2013;22. doi: 10.1177/0271678X19882788.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678X19882788</ArticleId><ArticleId IdType="pmc">PMC6928555</ArticleId><ArticleId IdType="pubmed">31645178</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmichael S.T., Kathirvelu B., Schweppe C.A., Nie E.H. Molecular, cellular and functional events in axonal sprouting after stroke. Exp. Neurol. 2016;287:384. doi: 10.1016/j.expneurol.2016.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2016.02.007</ArticleId><ArticleId IdType="pmc">PMC4980303</ArticleId><ArticleId IdType="pubmed">26874223</ArticleId></ArticleIdList></Reference><Reference><Citation>Kane E., Ward N.S. Neurobiology of Stroke Recovery. In: Platz T., editor. Clinical Pathways in Stroke Rehabilitation. Springer Nature; Cham, Switzerland: 2021. pp. 1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-58505-1_1</ArticleId><ArticleId IdType="pubmed">36315699</ArticleId></ArticleIdList></Reference><Reference><Citation>Loubinoux I., Brihmat N., Castel-Lacanal E., Marque P. Cerebral imaging of post-stroke plasticity and tissue repair. Rev. Neurol. 2017;173:577&#x2013;583. doi: 10.1016/j.neurol.2017.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2017.09.007</ArticleId><ArticleId IdType="pubmed">28985963</ArticleId></ArticleIdList></Reference><Reference><Citation>Feda S., Nikoubashman O., Schurmann K., Matz O., Tauber S.C., Wiesmann M., Schulz J.B., Reich A. Endovascular stroke treatment does not preclude high thrombolysis rates. Eur. J. Neurol. 2019;26:428-e33. doi: 10.1111/ene.13831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13831</ArticleId><ArticleId IdType="pubmed">30317687</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunz A., Dirnagl U., Mergenthaler P. Acute pathophysiological processes after ischaemic and traumatic brain injury. Best Pract. Res. Clin. Anaesthesiol. 2010;24:495&#x2013;509. doi: 10.1016/j.bpa.2010.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2010.10.001</ArticleId><ArticleId IdType="pubmed">21619862</ArticleId></ArticleIdList></Reference><Reference><Citation>Mogi M., Iwanami J., Horiuchi M. Roles of brain angiotensin II in cognitive function and dementia. Int. J. Hypertens. 2012:169649. doi: 10.1155/2012/169649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/169649</ArticleId><ArticleId IdType="pmc">PMC3529904</ArticleId><ArticleId IdType="pubmed">23304450</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright J.W., Kawas L.H., Harding J.W. A role for the brain RAS in Alzheimer&#x2019;s and Parkinson&#x2019;s diseases. Front. Endocrinol. 2013;4:158. doi: 10.3389/fendo.2013.00158.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2013.00158</ArticleId><ArticleId IdType="pmc">PMC3829467</ArticleId><ArticleId IdType="pubmed">24298267</ArticleId></ArticleIdList></Reference><Reference><Citation>Haspula D., Clark M.A. Molecular Basis of the Brain Renin Angiotensin System in Cardiovascular and Neurologic Disorders: Uncovering a Key Role for the Astroglial Angiotensin Type 1 Receptor AT1R. J. Pharmacol. Exp. Ther. 2018;366:251&#x2013;264. doi: 10.1124/jpet.118.248831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.118.248831</ArticleId><ArticleId IdType="pubmed">29752427</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Bohlen und Halbach O., Walther T., Bader M., Albrecht D. Interaction between Mas and the angiotensin AT1 receptor in the amygdala. J. Neurophysiol. 2000;83:2012&#x2013;2021. doi: 10.1152/jn.2000.83.4.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.2000.83.4.2012</ArticleId><ArticleId IdType="pubmed">10758111</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang S., Wang H.F., Wang X., Li J., Xing C.M. The association of renin-angiotensin system blockade use with the risks of cognitive impairment of aging and Alzheimer&#x2019;s disease: A meta-analysis. J. Clin. Neurosci. 2016;33:32&#x2013;38. doi: 10.1016/j.jocn.2016.02.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2016.02.036</ArticleId><ArticleId IdType="pubmed">27475317</ArticleId></ArticleIdList></Reference><Reference><Citation>Kane R.L., Butler M., Fink H.A., Brasure M., Davila H., Desai P., Jutkowitz E., McCreedy E., Nelson V.A., McCarten J.R., et al. Interventions to Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer&#x2019;s-Type Dementia. Agency for Healthcare Research and Quality; Rockville, MD, USA: 2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">28759193</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang T., Gao L., Guo J., Lu J., Wang Y., Zhang Y. Suppressing inflammation by inhibiting the NFkappaB pathway contributes to the neuroprotective effect of angiotensin-(1-7) in rats with permanent cerebral ischaemia. Br. J. Pharmacol. 2012;167:1520&#x2013;1532. doi: 10.1111/j.1476-5381.2012.02105.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1476-5381.2012.02105.x</ArticleId><ArticleId IdType="pmc">PMC3514764</ArticleId><ArticleId IdType="pubmed">22817481</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang T., Yu J.-T., Zhu X.-C., Zhang Q.-Q., Tan M.-S., Cao L., Wang H.-F., Lu J., Gao Q., Zhang Y.-D., et al. Angiotensin-(1-7) induces cerebral ischaemic tolerance by promoting brain angiogenesis in a Mas/eNOS-dependent pathway. Br. J. Pharmacol. 2014;171:4222&#x2013;4232. doi: 10.1111/bph.12770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.12770</ArticleId><ArticleId IdType="pmc">PMC4241089</ArticleId><ArticleId IdType="pubmed">24824997</ArticleId></ArticleIdList></Reference><Reference><Citation>Regenhardt R.W., Desland F., Mecca A.P., Pioquinto D.J., Afzal A., Mocco J., Sumners C. Anti-inflammatory effects of angiotensin-(1-7) in ischemic stroke. Neuropharmacology. 2013;71:154&#x2013;163. doi: 10.1016/j.neuropharm.2013.03.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2013.03.025</ArticleId><ArticleId IdType="pmc">PMC3664115</ArticleId><ArticleId IdType="pubmed">23583926</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson L.D., Eldahshan W., Fagan S.C., Ergul A. Within the Brain: The Renin Angiotensin System. Int. J. Mol. Sci. 2018;19:876. doi: 10.3390/ijms19030876.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19030876</ArticleId><ArticleId IdType="pmc">PMC5877737</ArticleId><ArticleId IdType="pubmed">29543776</ArticleId></ArticleIdList></Reference><Reference><Citation>Haraguchi T., Iwasaki K., Takasaki K., Uchida K., Naito T., Nogami A., Kubota K., Shindo T., Uchida N., Katsurabayashi S., et al. Telmisartan, a partial agonist of peroxisome proliferator-activated receptor, improves impairment of spatial memory and hippocampal apoptosis in rats treated with repeated cerebral ischemia. Brain Res. 2010;1353:125&#x2013;132. doi: 10.1016/j.brainres.2010.07.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2010.07.017</ArticleId><ArticleId IdType="pubmed">20637184</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishi T., Hirooka Y., Sunagawa K. Telmisartan protects against cognitive decline via up-regulation of brain-derived neurotrophic factor/tropomyosin-related kinase B in hippocampus of hypertensive rats. J. Cardiol. 2012;60:489&#x2013;494. doi: 10.1016/j.jjcc.2012.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jjcc.2012.08.004</ArticleId><ArticleId IdType="pubmed">22948091</ArticleId></ArticleIdList></Reference><Reference><Citation>Min L.J., Mogi M., Shudou M., Jing F., Tsukuda K., Ohshima K., Iwanami J., Horiuchi M. Peroxisome proliferator-activated receptor-activation with angiotensin II type 1 receptor blockade is pivotal for the prevention of blood-brain barrier impairment and cognitive decline in type 2 diabetic mice. Hypertension. 2012;59:1079&#x2013;1088. doi: 10.1161/HYPERTENSIONAHA.112.192401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.112.192401</ArticleId><ArticleId IdType="pubmed">22454480</ArticleId></ArticleIdList></Reference><Reference><Citation>Ongali B., Nicolakakis N., Tong X.K., Aboulkassim T., Papadopoulos P., Rosa-Neto P., Lecrux C., Imboden H., Hamel E. Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer&#x2019;s disease model. Neurobiol. Dis. 2014;68:126&#x2013;136. doi: 10.1016/j.nbd.2014.04.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.04.018</ArticleId><ArticleId IdType="pubmed">24807206</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamel E., Royea J., Ongali B., Tong X.K. Neurovascular and cognitive failure in Alzheimer&#x2019;s disease: Benefits of cardiovascular therapy. Cell. Mol. Neurobiol. 2016;36:219&#x2013;232. doi: 10.1007/s10571-015-0285-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-015-0285-4</ArticleId><ArticleId IdType="pubmed">26993506</ArticleId></ArticleIdList></Reference><Reference><Citation>Anil Kumar K.V., Nagwar S., Thyloor R., Satyanarayana S. Anti-stress and nootropic activity of drugs affecting the renin-angiotensin system in rats based on indirect biochemical evidence. J. Renin Angiotensin Aldosterone Syst. 2015;16:801&#x2013;812. doi: 10.1177/1470320313516173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1470320313516173</ArticleId><ArticleId IdType="pubmed">24496517</ArticleId></ArticleIdList></Reference><Reference><Citation>Douma B.R., Korte S.M., Buwalda B., la Fleur S.E., Bohus B., Luiten P.G. Repeated blockade of mineralocorticoid receptors, but not of glucocorticoid receptors impairs food rewarded spatial learning. Psychoneuroendocrinology. 1998;23:33&#x2013;44. doi: 10.1016/S0306-4530(97)00091-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0306-4530(97)00091-7</ArticleId><ArticleId IdType="pubmed">9618750</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishrat T., Pillai B., Soliman S., Fouda A.Y., Kozak A., Johnson M.H., Ergul A., Fagan S.C. Low-dose candesartan enhances molecular mediators of neuroplasticity and subsequent functional recovery after ischemic stroke in rats. Mol. Neurobiol. 2015;51:1542&#x2013;1553. doi: 10.1007/s12035-014-8830-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-8830-6</ArticleId><ArticleId IdType="pmc">PMC4677667</ArticleId><ArticleId IdType="pubmed">25084762</ArticleId></ArticleIdList></Reference><Reference><Citation>Soliman S., Ishrat T., Pillai A., Somanath P.R., Ergul A., El-Remessy A.B., Fagan S.C. Candesartan induces a prolonged proangiogenic effect and augments endothelium-mediated neuroprotection after oxygen and glucose deprivation: Role of vascular endothelial growth factors A and B. J. Pharmacol. Exp. Ther. 2014;349:444&#x2013;457. doi: 10.1124/jpet.113.212613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.113.212613</ArticleId><ArticleId IdType="pmc">PMC4019323</ArticleId><ArticleId IdType="pubmed">24681872</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodiga V.L., Bodiga S. Renin angiotensin system in cognitive function and dementia. Asian J. Neurosci. 2013;2013:102602. doi: 10.1155/2013/102602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/102602</ArticleId></ArticleIdList></Reference><Reference><Citation>Gadelha A., Vendramini A.M., Yonamine C.M., Nering M., Berberian A., Suiama M.A., Oliveira V., Lima-Landman M.T., Breen G., Bressan R.A., et al. Convergent evidences from human and animal studies implicate angiotensin I-converting enzyme activity in cognitive performance in schizophrenia. Transl. Psychiatry. 2015;5:e691. doi: 10.1038/tp.2015.181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/tp.2015.181</ArticleId><ArticleId IdType="pmc">PMC5068582</ArticleId><ArticleId IdType="pubmed">26645626</ArticleId></ArticleIdList></Reference><Reference><Citation>Wincewicz D., Juchniewicz A., Waszkiewicz N., Braszko J.J. Angiotensin II type 1 receptor blockade by telmisartan prevents stress-induced impairment of memory via HPA axis deactivation and up-regulation of brain-derived neurotrophic factor gene expression. Pharmacol. Biochem. Behav. 2016;148:108&#x2013;118. doi: 10.1016/j.pbb.2016.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pbb.2016.06.010</ArticleId><ArticleId IdType="pubmed">27375198</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee T.C., Greene-Schloesser D., Payne V., Diz D.I., Hsu F.C., Kooshki M., Mustafa R., Riddle D.R., Zhao W., Chan M.D., et al. Chronic administration of the angiotensin-converting enzyme inhibitor, ramipril, prevents fractionated whole-brain irradiation-induced perirhinal cortex-dependent cognitive impairment. Radiat. Res. 2012;178:46&#x2013;56. doi: 10.1667/RR2731.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1667/RR2731.1</ArticleId><ArticleId IdType="pmc">PMC3422865</ArticleId><ArticleId IdType="pubmed">22687052</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing F., Mogi M., Sakata A., Iwanami J., Tsukuda K., Ohshima K., Min L.J., Steckelings U.M., Unger T., Dahlof B., et al. Direct stimulation of angiotensin II type 2 receptor enhances spatial memory. J. Cereb. Blood Flow Metab. 2012;32:248&#x2013;255. doi: 10.1038/jcbfm.2011.133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2011.133</ArticleId><ArticleId IdType="pmc">PMC3272601</ArticleId><ArticleId IdType="pubmed">21971355</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakata A., Mogi M., Iwanami J., Tsukuda K., Min L.J., Fujita T., Iwai M., Ito M., Horiuchi M. Sex-different effect of angiotensin II type 2 receptor on ischemic brain injury and cognitive function. Brain Res. 2009;1300:14&#x2013;23. doi: 10.1016/j.brainres.2009.08.068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2009.08.068</ArticleId><ArticleId IdType="pubmed">19729000</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho J.K., Nation D.A. Memory is preserved in older adults taking AT1 receptor blockers. Alzheimers Res. Ther. 2017;9:33. doi: 10.1186/s13195-017-0255-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-017-0255-9</ArticleId><ArticleId IdType="pmc">PMC5405458</ArticleId><ArticleId IdType="pubmed">28446207</ArticleId></ArticleIdList></Reference><Reference><Citation>Igic R., Skrbic R. The renin-angiotensin system and its blockers. Srp. Arh. Celok. Lek. 2014;142:756&#x2013;763. doi: 10.2298/SARH1412756I.</Citation><ArticleIdList><ArticleId IdType="doi">10.2298/SARH1412756I</ArticleId><ArticleId IdType="pubmed">25731011</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J.L., Li G.Z., Chen S.Z., Wang J.J., Olson J.E., Xia H.J., Lazartigues E., Zhu Y.-L., Chen Y.-F. Angiotensin converting enzyme 2/Ang-(1-7)/Mas Axis protects brain from ischemic injury with a tendency of age-dependence. CNS Neurosci Ther. 2014;20:452&#x2013;459. doi: 10.1111/cns.12233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.12233</ArticleId><ArticleId IdType="pmc">PMC4840841</ArticleId><ArticleId IdType="pubmed">24581232</ArticleId></ArticleIdList></Reference><Reference><Citation>Juliana C., Fernandes-Alnemri T., Wu J., Datta P., Solorzano L., Yu J.W., Meng R., Quong A.A., Latz R., Scott C.P., et al. Anti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome. J. Biol. Chem. 2010;285:9792&#x2013;9802. doi: 10.1074/jbc.M109.082305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.082305</ArticleId><ArticleId IdType="pmc">PMC2843228</ArticleId><ArticleId IdType="pubmed">20093358</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y., Varadarajan S., Mu&#xf1;oz-Planillo R., Burberry A., Nakamura Y., N&#xfa;&#xf1;ez G. 3,4-methylenedioxy-&#x3b2;-nitrostyrene inhibits NLRP3 inflammasome activation by blocking assembly of the inflammasome. J. Biol. Chem. 2014;289:1142&#x2013;1150. doi: 10.1074/jbc.M113.515080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.515080</ArticleId><ArticleId IdType="pmc">PMC3887181</ArticleId><ArticleId IdType="pubmed">24265316</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y., Jiang W., Spinetti T., Tardivel A., Castillo R., Bourquin C., Guarda G., Tian Z., Tschopp J., Zhou R. Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity. 2013;38:1154&#x2013;1163. doi: 10.1016/j.immuni.2013.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2013.05.015</ArticleId><ArticleId IdType="pubmed">23809162</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin H., Guo Q., Li X., Tang T., Li C., Wang H., Sun Y., Feng Q., Ma C., Gao C., et al. Curcumin suppresses IL-1&#x3b2; secretion and prevents inflammation through inhibition of the NLRP3 inflammasome. J. Immunol. 2018;200:2835&#x2013;2846. doi: 10.4049/jimmunol.1701495.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1701495</ArticleId><ArticleId IdType="pubmed">29549176</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Cao Y., Dang C., Han B., Han R., Ma H., Hao J., Wang L. Inhibition of double-strand DNA-sensing cGAS ameliorates brain injury after ischemic stroke. EMBO Mol. Med. 2020;12:e11002. doi: 10.15252/emmm.201911002.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201911002</ArticleId><ArticleId IdType="pmc">PMC7136961</ArticleId><ArticleId IdType="pubmed">32239625</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo Z., Tang C., Li H., Lei J., Zhu L., Kou L., Li H., Luo S., Li C., Chen W., et al. Eicosapentaenoic acid prevents inflammation induced by acute cerebral infarction through inhibition of NLRP3 inflammasome activation. Life Sci. 2020;242:117133. doi: 10.1016/j.lfs.2019.117133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2019.117133</ArticleId><ArticleId IdType="pubmed">31830477</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu J., Wang M., Zhang J., Cai Q., Lu D., Li Y., Dong Y., Zhao T., Chen H. The neuroprotection of sinomenine against ischemic stroke in mice by suppressing NLRP3 inflammasome via AMPK signaling. Int. Immunopharmacol. 2016;40:492&#x2013;500. doi: 10.1016/j.intimp.2016.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2016.09.024</ArticleId><ArticleId IdType="pubmed">27769021</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Jiang L., Che F., Lu Y., Xie Z., Wang H. Arctigenin attenuates ischemic stroke via SIRT1-dependent inhibition of NLRP3 inflammasome. Biochem. Biophys Res. Commun. 2017;493:821&#x2013;826. doi: 10.1016/j.bbrc.2017.08.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2017.08.062</ArticleId><ArticleId IdType="pubmed">28888980</ArticleId></ArticleIdList></Reference><Reference><Citation>Fann D.Y., Lee S.Y., Manzanero S., Tang S.C., Gelderblom M., Chunduri P., Bernreuther C., Glatzel M., Cheng Y.L., Thundyil J., et al. Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome mediated neuronal death in ischemic stroke. Cell Death Dis. 2013;4:e790. doi: 10.1038/cddis.2013.326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2013.326</ArticleId><ArticleId IdType="pmc">PMC3789184</ArticleId><ArticleId IdType="pubmed">24008734</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Li R., Wang X., Fu Q., Ma S. Umbelliferone ameliorates cerebral ischemia-reperfusion injury via upregulating the PPAR gamma expression and suppressing TXNIP/NLRP3 inflammasome. Neurosci. Lett. 2015;600:182&#x2013;187. doi: 10.1016/j.neulet.2015.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2015.06.016</ArticleId><ArticleId IdType="pubmed">26071904</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Gu Y., Liu J. BRD4 suppression alleviates cerebral ischemia-induced brain injury by blocking glial activation via the inhibition of inflammatory response and pyroptosis. Biochem. Biophys. Res. Commun. 2019;519:481&#x2013;488. doi: 10.1016/j.bbrc.2019.07.097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2019.07.097</ArticleId><ArticleId IdType="pubmed">31530390</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Y., Jin T., Zhang X., Zeng Z., Ye B., Wang J., Zhong Y., Xiong X., Gu L. Meisoindigo protects against focal cerebral ischemia-reperfusion injury by inhibiting NLRP3 inflammasome activation and regulating microglia/macrophage polarization via TLR4/NF-&#x3ba;B signaling pathway. Front. Cell Neurosci. 2019;13:553. doi: 10.3389/fncel.2019.00553.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00553</ArticleId><ArticleId IdType="pmc">PMC6930809</ArticleId><ArticleId IdType="pubmed">31920554</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Huang L., Liu G., Fan W., Li B., Liu R., Wang Z., Fan Q., Xiao W., Li T. Ginkgo diterpene lactones inhibit cerebral ischemia/reperfusion induced inflammatory response in astrocytes via TLR4/NF-&#x3ba;B pathway in rats. J. Ethnopharmacol. 2020;249:112365. doi: 10.1016/j.jep.2019.112365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2019.112365</ArticleId><ArticleId IdType="pubmed">31678414</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y., Xiao G., Luo W. Minocycline suppresses NLRP3 inflammasome activation in experimental ischemic stroke. Neuroimmunomodulation. 2016;23:230&#x2013;238. doi: 10.1159/000452172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000452172</ArticleId><ArticleId IdType="pubmed">27846628</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N., Zhang X., Liu X., Wang H., Xue J., Yu J., Kang N., Wang X. Chrysophanol inhibits NALP3 inflammasome activation and ameliorates cerebral ischemia/reperfusion in mice. Mediat. Inflamm. 2014:370530. doi: 10.1155/2014/370530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/370530</ArticleId><ArticleId IdType="pmc">PMC4020303</ArticleId><ArticleId IdType="pubmed">24876671</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Wang J., Fang Y., Liu Y., Chen T., Sun H., Zhou X.-F., Liao H. Nafamostat mesylate improves function recovery after stroke by inhibiting neuroinflammation in rats. Brain Behav. Immun. 2016;56:230&#x2013;245. doi: 10.1016/j.bbi.2016.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2016.03.019</ArticleId><ArticleId IdType="pubmed">27033633</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Zhang X., Ding Y., Zhou W., Tao L., Lu P., Wang Y., Hu R. Nuclear factor E2-related factor-2 negatively regulates NLRP3 Inflammasome activity by inhibiting reactive oxygen species-induced NLRP3 priming. Antioxid. Redox Signal. 2017;26:28&#x2013;43. doi: 10.1089/ars.2015.6615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2015.6615</ArticleId><ArticleId IdType="pmc">PMC5198158</ArticleId><ArticleId IdType="pubmed">27308893</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang M.Y., Tu C.E., Wang S.C., Hung Y.L., Su C.C., Fang S.H., Chen C.S., Liu P.L., Cheng W.C., Huang Y.W., et al. Corylin inhibits LPS-induced inflammatory response and attenuates the activation of NLRP3 inflammasome in microglia. BMC Complement Altern Med. 2018;18:221. doi: 10.1186/s12906-018-2287-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12906-018-2287-5</ArticleId><ArticleId IdType="pmc">PMC6092865</ArticleId><ArticleId IdType="pubmed">30107806</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao A.P., Dong Y.F., Liu W., Gu J., Sun X.L. Nicorandil inhibits inflammasome activation and Toll-like receptor-4 signal transduction to protect against oxygen-glucose deprivation-induced inflammation in BV-2 cells. CNS Neurosci. Ther. 2014;20:147&#x2013;153. doi: 10.1111/cns.12178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.12178</ArticleId><ArticleId IdType="pmc">PMC6493004</ArticleId><ArticleId IdType="pubmed">24256503</ArticleId></ArticleIdList></Reference><Reference><Citation>Jian Z., Ding S., Deng H., Wang J., Yi W., Wang L., Zhu S., Gu L., Xiong X. Probenecid protects against oxygen-glucose deprivation injury in primary astrocytes by regulating inflammasome activity. Brain Res. 2016;1643:123&#x2013;129. doi: 10.1016/j.brainres.2016.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.05.002</ArticleId><ArticleId IdType="pubmed">27154322</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren H., Kong Y., Liu Z., Zang D., Yang X., Wood K., Li M., Liu Q. Selective NLRP3 (Pyrin Domain-Containing Protein 3) Inflammasome Inhibitor reduces brain injury after intracerebral hemorrhage. Stroke. 2018;49:184&#x2013;192. doi: 10.1161/STROKEAHA.117.018904.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.117.018904</ArticleId><ArticleId IdType="pmc">PMC5753818</ArticleId><ArticleId IdType="pubmed">29212744</ArticleId></ArticleIdList></Reference><Reference><Citation>Coll R.C., Robertson A.A., Chae J.J., Higgins S.C., Mu&#xf1;oz-Planillo R., Inserra M.C., Vetter I., Dungan L.S., Monks B.G., Stutz A., et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat. Med. 2015;21:248&#x2013;255. doi: 10.1038/nm.3806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3806</ArticleId><ArticleId IdType="pmc">PMC4392179</ArticleId><ArticleId IdType="pubmed">25686105</ArticleId></ArticleIdList></Reference><Reference><Citation>Newman Z.L., Sirianni N., Mawhinney C., Lee M.S., Leppla S.H., Moayeri M., Johansen L.M. Auranofin protects against anthrax lethal toxin-induced activation of the Nlrp1b inflammasome. Antimicrob. Agents Chemother. 2011;55:1028&#x2013;1035. doi: 10.1128/AAC.00772-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00772-10</ArticleId><ArticleId IdType="pmc">PMC3067098</ArticleId><ArticleId IdType="pubmed">21149629</ArticleId></ArticleIdList></Reference><Reference><Citation>Grefkes C., Fink G.R. Recovery from stroke: Current concepts and future perspectives. Neurol. Res. Pract. 2020;2:17. doi: 10.1186/s42466-020-00060-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42466-020-00060-6</ArticleId><ArticleId IdType="pmc">PMC7650109</ArticleId><ArticleId IdType="pubmed">33324923</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmud-Al-Rafat A., Asim M.M.H., Taylor-Robinson A.W., Majumder A., Muktadir A., Muktadir H., Karim M., Khan I., Ahasan M.M., Billah M.M. A combinational approach to restore cytokine balance and to inhibit virus growth may promote patient recovery in severe COVID-19 cases. Cytokine. 2020;136:155228. doi: 10.1016/j.cyto.2020.155228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2020.155228</ArticleId><ArticleId IdType="pmc">PMC7428755</ArticleId><ArticleId IdType="pubmed">32822911</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>